HOMA-IR: the simple calculation that maps insulin resistance
The short version: a one-line formula using two cheap labs that often catches metabolic trouble years before standard glucose tests do.
TL;DR
- HOMA-IR is calculated from a single fasting blood draw — fasting insulin and fasting glucose.
- The formula: (fasting insulin × fasting glucose) ÷ 405. Below ~1.0 is generally healthy; above ~2.0 commonly indicates insulin resistance.
- It catches metabolic trouble that A1C and fasting glucose can miss for years.
What it is
HOMA-IR (in plain English: Homeostatic Model Assessment of Insulin Resistance — a simple math formula that estimates how much extra insulin the pancreas is having to release to keep blood sugar in range) was first published in 1985 (Matthews et al., Diabetologia, 1985). It is calculated from one fasting blood draw — no oral glucose tolerance test, no overnight clinic stay. Because it incorporates fasting insulin (which most standard panels skip), it gives a different and earlier window into metabolic health than A1C or fasting glucose alone.
How it works
Think of insulin like a thermostat trying to hold a room at a target temperature. The room is your bloodstream; the temperature is glucose. If the heating system is working well, you only need a small amount of fuel (insulin) to hold the target. If the room is leaky, the thermostat has to work harder — pumping out more insulin — to keep glucose where it should be. HOMA-IR measures how hard that thermostat is working. The CDC estimates that more than 1 in 3 American adults has prediabetes, much of which precedes any abnormal fasting glucose (CDC Diabetes Statistics, 2024).
Who asks about it
People come to this topic when their fasting glucose looks “fine” but they suspect something is off — energy crashes after meals, weight gain that does not match diet, family history of type 2 diabetes. They want a number that shows whether the metabolic engine is straining.
What the research says
The original 1985 paper validated HOMA-IR against the gold-standard hyperinsulinemic-euglycemic clamp and found strong correlation in non-diabetic adults (Matthews et al., 1985). HOMA-IR is now widely used in clinical research and is a standard endpoint in metabolic studies. The number is most useful in people who do not yet have diabetes; in established diabetes, it loses some interpretive power because the pancreas is no longer keeping up with demand.
What to know before considering it
HOMA-IR requires fasting insulin, which is not on a standard metabolic panel. Ask for it specifically. Recent steroid use, acute illness, or recent intense exercise can shift the number. Pair it with A1C and fasting glucose to see the full picture.
The Halftime POV
HOMA-IR is one of the cheapest, highest-signal numbers in metabolic medicine. Two simple labs, one short equation, and a much earlier read on whether the metabolic engine is straining than standard tests give you. Worth tracking.
Related reading:
- Fasting insulin: the metabolic marker your standard panel might miss
- A1C and fasting glucose: the two metabolic baselines
- The baseline blood panel: what to test before any peptide protocol
FAQ
Q: How do you calculate HOMA-IR? A: HOMA-IR equals fasting insulin (in microunits per milliliter) multiplied by fasting glucose (in milligrams per deciliter), divided by 405. Both values come from one fasting blood draw.
Q: What is a normal HOMA-IR? A: Lab cutoffs vary, but values below about 1.0 are typically described as healthy insulin sensitivity, while values above 2.0 commonly indicate meaningful insulin resistance. Clinicians read the number alongside A1C and other context.
Q: Is HOMA-IR better than fasting glucose alone? A: It captures something fasting glucose misses: how much insulin the pancreas is having to put out to keep glucose normal. Two people can have the same fasting glucose with very different HOMA-IR values.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.
